Abstract
BackgroundChronic inflammation contributes to enhanced cardiovascular risk in patients with rheumatoid arthritis (RA). Biologic disease modifying antirheumatic drugs (bDMARDs) have been shown to effectively control inflammation in many conventional synthetic...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have